미분류

Access Bio gets US$2m from Bill & Melinda Gates Foundation

By 김지현
  • Published : Sept 9, 2016 - 17:15
  • Updated : Sept 9, 2016 - 17:15
[THE INVESTOR]  South Korean Access Bio will be receiving US$1.83 million funds from the Bill & Melina Gates Foundation for research purposes.

The research period will be between September 2016 and January 2018.

The funding will be used to fine-tune the firm’s Ultra-HST platform technology it developed for speedy and accurate diagnosis of malaria -- even in patients who fail to show symptoms.

In March, Access Bio had received a US$800 million fund from the Global Health Investment Fund created by the Bill Gates Foundation.

By Kim Ji-hyun(jemmie@heraldcorp.com)